必贝特新股发行结果出炉

Core Insights - The company, Bibet, announced the results of its new stock issuance, with online investors subscribing to 21.5392 million shares, amounting to 383 million yuan, while offline investors fully subscribed [2][3] - The total issuance was 90 million shares at a price of 17.78 yuan per share, with online subscriptions accounting for 24% of the total issuance [3] Online Subscription Details - Online subscription quantity: 21.5392 million shares - Online subscription amount: 383 million yuan - Online abandonment quantity: 60,800 shares, with an abandonment rate of 0.281264% and an abandonment amount of 1.0802 million yuan [2][3] - Final online issuance quantity: 21.6 million shares, with a final winning rate of 0.04772481% [3] Offline Subscription Details - Offline subscription quantity: 50.4 million shares - Offline subscription amount: 896.112 million yuan - No abandonment from offline investors, with all shares fully subscribed [2][3] Company Focus - Bibet specializes in the treatment of major diseases such as tumors, autoimmune diseases, and metabolic diseases, with core products classified as Class 1 new chemical drugs [3] - The main therapeutic areas include malignant lymphoma, breast cancer, non-small cell lung cancer, ovarian cancer, psoriasis, and diabetes with non-alcoholic fatty liver disease [3]